
Lowering Lipoprotein(a): ApoB, PCSK9 Inhibitors and New Drugs in 2026
Pelacarsen lowered Lp(a) markedly yet missed its trial goal. What Lp(a), ApoB, PCSK9 inhibitors and new Lp(a) drugs actually show as of 2026.
Read the article: Lowering Lipoprotein(a): ApoB, PCSK9 Inhibitors and New Drugs in 2026







